Targeted therapies: aiming for the bull's-eye

ONS Connect. 2007 Jul;22(7):8-12.
No abstract available

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Apoptosis / drug effects
  • Cell Transformation, Neoplastic / drug effects
  • Clinical Trials as Topic / nursing
  • Drug Costs
  • Drug Delivery Systems / economics
  • Drug Delivery Systems / methods*
  • Drug Delivery Systems / nursing*
  • Drug Design
  • ErbB Receptors / antagonists & inhibitors
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / etiology
  • Neoplasms / nursing
  • Nurse's Role
  • Oncology Nursing
  • Receptor, ErbB-2 / antagonists & inhibitors

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • ErbB Receptors
  • Receptor, ErbB-2